Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Generic Palbociclib is safe and tolerable for treating certain breast cancer types.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

The HDDPiW-jSB solution may prevent hair loss caused by docetaxel in rats when applied regularly.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

Apraglutide and N-acetylcysteine (NAC) show promise in reducing cytarabine's harmful effects on organs.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.